Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting

Author:

Beenakker Jan-Willem M.ORCID,Brouwer Niels J.ORCID,Chau Cindy,Coupland Sarah E.ORCID,Fiorentzis MiltiadisORCID,Heimann Heinrich,Heufelder Jens,Joussen Antonia M.,Kiilgaard Jens F.ORCID,Kivelä Tero T.ORCID,Piperno-Neumann Sophie,Rantala Elina S.ORCID,Romanovska-Dixon Bozena,Shields Carol L.ORCID,Willerding Gregor D.,Wheeler-Schilling Thomas,Scholl Hendrik P.N.ORCID,Jager Martine J.,Damato Bertil E.

Abstract

Uveal Melanoma (UM) is the most common primary intra-ocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on “Outcome Measures of New Technologies in Uveal Melanoma”, addressing the latest advances in UM, starting with genetic developments, then moving on to imaging and treatment of the primary tumor, as well as to investigating the most recent developments in treating metastases, and eventually taking care of the patient’s wellbeing. This review highlights the meeting’s presentations in the context of the published literature.

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3